# VANFLYTA
> **NDA216993** · New Drug Application · Sponsor: DAIICHI SANKYO INC · Approved 2023-07-20
## Drug
- **FDA Application Number:** NDA216993
- **Application type:** New Drug Application
- **Brand name:** VANFLYTA
- **Generic name:** QUIZARTINIB
- **Active ingredients:** QUIZARTINIB DIHYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** DAIICHI SANKYO INC
- **Manufacturer:** Daiichi Sankyo Inc.
- **First approval:** 2023-07-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216993)
---
*MORVS · CC0 1.0*